Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-blind, Multicenter Study to Investigate the Safety and Duration of Effect of Different NT 201 Dose Groups Following the Treatment of Glabellar Frown Lines

NCT03806933 is registered in ClinicalTrials.gov with Merz Aesthetics GmbH as lead sponsor.

NCT NCT03806933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03806933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-blind, Multicenter Study to Investigate the Safety and Duration of Effect of Different NT 201 Dose Groups Following the Treatment of Glabellar Frown Lines
Lead sponsor
Merz Aesthetics GmbH
Phase
Phase 2
Overall status
Completed
Start date
January 23, 2019
Completion date
October 8, 2020
Enrollment
241 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe glabellar frown lines